Home » Unigene In-Licenses Potential Therapies for Inflammation and Cardiovascular Disease From University of London
Unigene In-Licenses Potential Therapies for Inflammation and Cardiovascular Disease From University of London
Unigene Laboratories, Inc. has acquired exclusive commercial rights to a combination therapy with potential value in the treatment of certain inflammatory diseases, and a novel peptide that may find application in the treatment of certain cardiovascular diseases.
Unigene
Upcoming Events
-
07May
-
14May
-
30May